相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Large-Scale Characterization of DNA Methylation Changes in Human Gastric Carcinomas with and without Metastasis
Zhaojun Liu et al.
CLINICAL CANCER RESEARCH (2014)
Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition
Paul Roepman et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma
Miwako Kakiuchi et al.
NATURE GENETICS (2014)
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
Kai Wang et al.
NATURE GENETICS (2014)
Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery
Jeeyun Lee et al.
PLOS ONE (2014)
Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing
Swee Seong Wong et al.
NATURE COMMUNICATIONS (2014)
Identification of Molecular Subtypes of Gastric Cancer With Different Responses to PI3-Kinase Inhibitors and 5-Fluorouracil
Zhengdeng Lei et al.
GASTROENTEROLOGY (2013)
Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer
Yonghui Wu et al.
GUT (2013)
Genotyping and Genomic Profiling of Non-Small-Cell Lung Cancer: Implications for Current and Future Therapies
Tianhong Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello et al.
NATURE GENETICS (2013)
Comparison of Global Gene Expression of Gastric Cardia and Noncardia Cancers from a High-Risk Population in China
Gangshi Wang et al.
PLOS ONE (2013)
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
Niantao Deng et al.
GUT (2012)
Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
Jeeyun Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
HER2 testing in gastric cancer: a practical approach
Josef Rueschoff et al.
MODERN PATHOLOGY (2012)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Methylation Subtypes and Large-Scale Epigenetic Alterations in Gastric Cancer
Hermioni Zouridis et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array Profiling
Domenico Coppola et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
EMT is the dominant program in human colon cancer
Andre Loboda et al.
BMC MEDICAL GENOMICS (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Gene Expression Signature-Based Prognostic Risk Score in Gastric Cancer
Jae Yong Cho et al.
CLINICAL CANCER RESEARCH (2011)
Molecular Classification of Gastric Cancer: A New Paradigm
Manish A. Shah et al.
CLINICAL CANCER RESEARCH (2011)
Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy
Iain Beehuat Tan et al.
GASTROENTEROLOGY (2011)
Targeted therapies for breast cancer
Michaele J. Higgins et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
Ramon Salazar et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
PICNIC: an algorithm to predict absolute allelic copy number variation with microarray cancer data
Chris D. Greenman et al.
BIOSTATISTICS (2010)
Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor
Yair Benita et al.
BLOOD (2010)
Host Inflammatory Response Predicts Survival of Patients With Epstein-Barr Virus-Associated Gastric Carcinoma
Hye-Jong Song et al.
GASTROENTEROLOGY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer
Chia Huey Ooi et al.
PLOS GENETICS (2009)
Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma
J. Lee et al.
ANNALS OF ONCOLOGY (2007)
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach
S Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients
HY Dai et al.
CANCER RESEARCH (2005)
Variation in gene expression patterns in human gastric cancers
X Chen et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Evaluation of tumor microsatellite instability using five quasi monomorphic mononucleotide repeats and pentaplex PCR
N Suraweera et al.
GASTROENTEROLOGY (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
